CHC Healthcare Group · TWSE:4164

CHC Healthcare — Investor Presentation (December 2020)

32 slides from CHC Healthcare's investor presentation, Dec 22, 2020

  1. Slide 1: CHC Healthcare Group 2020 2nd Investor Conference

    CHC Healthcare Group (4164TT) 2020 2nd Investor Conference 2020/12/22

  2. Slide 2: This document is provided by CHC Healthcare Group (CHC). Information contained in this document

    • This document is provided by CHC Healthcare Group (CHC). Information contained in this document has not been audited or reviewed by any accountants or independent experts. CHC makes no express or implied representations or warranties as to the fairness, accuracy, completeness, or correctness of su

  3. Slide 3: Dual ISO Certifications

    Dual ISO Certifications ISO 9001 Quality Management Systems OHSAS 18001 Occupational Health and Safety Management Systems

  4. Slide 4: Company Overview

    Company Business Latest Overview Results Updates

  5. Slide 5: Company Overview

    Company Business Latest Overview Results Updates

  6. Slide 6: Basic Information

    Basic Information • Company name: CHC Healthcare Group • Company code: 4164 TT • Date of establishment: 2009/11/27 (1st subsidiary, Chiu Ho Instruments & Reagent, was founded in 1977) • Chairman: Mr. Pei-Lin, Lee • Major business: Medical equipment distribution, Medical management service • Paid-in

  7. Slide 7: Global Locations

    Global Locations Taiwan China Indonesia • Taipei • Guangzhou • Jakarta (Headquarters) • Beijing • Taichung • Shenyang • Kaohsiung

  8. Slide 8: Milestones

    Milestones Established Chiu Ho Instruments & Reagents Co., Ltd. to engage in Listed in Taiwan Stock Exchange 1977 business of medical equipment distribution 2012 Became Taiwan exclusive distributor for IBA of proton therapy systems 1985 Entered the field of radiation oncology equipment Became Taiwan

  9. Slide 9: Business Model

    Business Model Manufacturer Medical Medical Equipment CHC Management Distribution Service Hospital & Clinic

  10. Slide 10: Solid Partnership with Top Global Brands

    Solid Partnership with Top Global Brands Radiation Oncology Neuroscience Ophthalmology Medical Imaging Surgery

  11. Slide 11: Medical Management Service Scope

    Medical Management Service Scope Division Operation Management Hospital Consulting Management Equipment Provider Site Site Operational Education Maintenance Installation Planning Construction Consulting & Training & Upgrade

  12. Slide 12: Professional Service Team

    Professional Service Team Yee-Min, Jen Chief Executive Officer Oncology Business Group (Director, Dept. of Radiation Oncology, Tri-Service General Hospital) Ming-Ta, Wen Dr. Chia-Ming, Wu Physician Oncology Business Group Oncology Business Group (Supervisor, Dept. of Radiation Oncology, Mennonite Ch

  13. Slide 13: Business Results

    Company Business Latest Overview Results Updates

  14. Slide 14: Product Mix

    Product Mix 2019 2020 Q1-Q3 2018 2019 Q1-Q3 56% 44% 53% 47% 59% 41% 47% 53% Revenue from medical equipment distribution Revenue from medical management service

  15. Slide 15: Operating Revenue

    Operating Revenue Operating revenue (NT$ thousand) 3,500,000 2,950,052 3,000,000 2,648,649 2,507,466 2,500,000 2,205,206 2,327,948 2,117,116 2,000,000 1,500,000 1,000,000 500,000 - 2016 2017 2018 2019 2019 Jan.- Nov. 2020 Jan.- Nov. (Self-assessed) (Self-assessed)

  16. Slide 16: Profitability

    Profitability Profit for the period Basic EPS (NT$ thousand) (NT$ ) 500,000 3 2.83 2.5 400,000 2.32 2.24 2.28 2 300,000 1.5 200,000 1.14 1 0.5 100,000 0 - 390,431 313,759 -0.5 160,604 -0.62 317,829 315,128 -100,000 -1 -89,286 2016 2017 2018 2019 2019 Q1-Q3 2020 Q1-Q3

  17. Slide 17: Earnings Distribution & Dividend Yield

    Earnings Distribution & Dividend Yield Cash dividends Dividend per share yield (NT$) 3 6% Cash dividends Average Dividend 2.5 5% per share closing price yield (NT$) 2 4% 2016 1.004 49.68 2% 2017 1.1 40.69 3% 1.5 3% 2018 1.8 33.87 5% 1 2% 2019 2 40.27 5% 0.5 1% 0 0% 2016 2017 2018 2019

  18. Slide 18: Latest Updates

    Company Business Latest Overview Results Updates

  19. Slide 19: IBA Proton Therapy

    IBA Proton Therapy 30+ YEARS 50%+ PATIENTS 55+ CENTERS LEADER IN PROTON THERAPY TREATED USING IBA TECHNOLOGY POWERED BY IBA WORLDWIDE

  20. Slide 20: IBA Proton Therapy

    IBA Proton Therapy Think Big, Scale Smart • Only compact solution with IMPT • S2C2: next generation cyclotron • Equip with Pencil Beam Scanning • Efficient workflow and operations ProteusONE

  21. Slide 21: IBA Proton Therapy Project Sharing

    IBA Proton Therapy Project Sharing Video - Cyclotron lifting

  22. Slide 22: IBA Proton Therapy Project Sharing

    IBA Proton Therapy Project Sharing Video- Gantry lifting

  23. Slide 23: Taiwan's Proton Therapy Market

    Taiwan's Proton Therapy Market Status Hospital Brand Choice Chang Gung Memorial Hospital Operating X Brand (Linkou, Kaohsiung) Current Treatment Costs Taipei Medical University Hospital IBA (take Taiwanese patient for example) Constructing National Taiwan University Hospital Y Brand NT$ 34,500 per t

  24. Slide 24: Elekta MR-Linac

    Cc 1C HEALTHCARE Sy GROUP Elekta MR-Linac Oblekta NEXT GENERATION LINAC With state-of-the-art, 160-leaf MLC 1.5T HIGH-FIELD MR IMAGING For crystal clear target visualization SLIP RING TECHNOLOGY Up to 6x faster gantry rotation for continuous treatment at any angle » Elekta Unity INTELLIGENT SOFTWARE

  25. Slide 25: Elekta MR-Linac

    Elekta MR-Linac Video - Unity fusion "We needed online, real-time, diagnostic quality MR imaging within the treatment workflow. Elekta Unity is the only system that can provide this." Professor Dr Daniel Zips, Medical Director, CCC Tübingen- Stuttgart, Germany

  26. Slide 26: Elekta MR-Linac

    Elekta MR-Linac @Elekta

  27. Slide 27: Taiwan's Radiation Therapy (RT) Market

    Taiwan's Radiation Therapy (RT) Market Hospitals with Medical Center with RT: 19 Dept. of Radiation Oncology 100 Regional Hospital with RT: 57 85 District Hospital with RT: 17 70 55 2015 2016 2017 2018 2019 Potential Customers *Source: Ministry of Health and Welfare

  28. Slide 28: Cyberdyne HAL

    Cyberdyne HAL® =| O7 THINK rs ee 02 SEND > “\ OSREAD \ ” Na O4move oe

  29. Slide 29: Cyberdyne HAL Project Sharing

    Cyberdyne HAL® Project Sharing Video - Rehabilitation

  30. Slide 30: Cyberdyne HAL Project Sharing

    Cyberdyne HAL® Project Sharing

  31. Slide 31: Taiwan's Rehabilitation (Rehab) Market

    Taiwan's Rehabilitation (Rehab) Market Rehab Clinic & Hospitals with Dept. of Rehab Medical Center with Rehab: 19 750 700 Regional Hospital with Rehab: 78 650 District Hospital with Rehab: 196 600 550 Rehab Clinic: More than 400 500 2015 2016 2017 2018 2019 Promotion Coverage *Source: Ministry of He

  32. Slide 32: Thank you!

    Thank you! www.chcg.com Copyright © 2019 CHC Limited. All rights reserved.

CHC Healthcare Group — Investor Presentation (December 2020) on 6ix